PINK1/Parkin-pathway mitophagy impairment in sporadic Parkinson's disease
🧪 Overview
Sporadic PD may include impaired mitochondrial quality control, reduced mitophagy flux, and dopaminergic vulnerability overlapping with PINK1/Parkin biology. The most defensible program is biomarker-led and should test whether candidate therapies restore mitochondrial flux and neuronal resilience rather than assuming canonical familial-PD mitophagy is dominant in all sporadic cases.
🧬 Mechanism
⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — PINK1;
No curated PDB or AlphaFold mapping for PINK1; yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for PINK1; PARK2; MFN2; OPTN.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |